Are you Dr. Sanford?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 60 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
2130 W Holcombe Blvd
10th Floor
Houston, TX 77030Phone+1 713-600-0900Fax+1 713-600-0070
Summary
- Dr. David Sanford, MD is an oncologist in Houston, Texas. He is currently licensed to practice medicine in Texas, North Carolina, and Wisconsin. He is affiliated with St. Luke's Health - Baylor St. Luke's Medical Center, Houston Methodist Hospital, and Memorial Hermann Physician Network.
Education & Training
University of Texas Health Science Center at HoustonFellowship, Hematology and Medical Oncology, 1991 - 1994
Texas A&M College of Medicine-Scott and White Medical Center (Temple)Residency, Internal Medicine, 1988 - 1991
McGovern Medical School at UTHealthClass of 1988
Certifications & Licensure
AR State Medical License 2024 - 2026
AZ State Medical License 2024 - 2026
DC State Medical License 2024 - 2026
TN State Medical License 2024 - 2026
NH State Medical License 2024 - 2026
WI State Medical License 2024 - 2025
WA State Medical License 2024 - 2025- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
- Join now to see all
Publications & Presentations
PubMed
- 14 citationsPhase II trial of ponatinib in patients with chronic myeloid leukemia resistant to one previous tyrosine kinase inhibitorDavid Sanford, Hagop M. Kantarjian, Jeffrey Skinner, Elias Jabbour, Jorge E. Cortes
Haematologica. 2015-12-01 - 11 citationsJumping Translocations in Myeloid Malignancies Associated With Treatment Resistance and Poor SurvivalDavid Sanford, Courtney D. DiNardo, Guilin Tang, Jorge E. Cortes, Srdan Verstovsek
Clinical Lymphoma, Myeloma & Leukemia. 2015-09-01 - 31 citationsTamibarotene in patients with acute promyelocytic leukaemia relapsing after treatment with all-trans retinoic acid and arsenic trioxideDavid Sanford, Francesco Lo-Coco, Miguel A. Sanz, Eros Di Bona, Steven Coutre
British Journal of Haematology. 2015-11-01
Press Mentions
Florida Hospitals Struggling to Get OxygenAugust 5th, 2021- Readout from the Trump Administration’s 43rd Governors Briefing on COVID-19 Response & Best PracticesNovember 30th, 2020
- Smallest Health Providers Face Biggest Problem Finding Protective Gear Amid Coronavirus SurgeNovember 22nd, 2020
Professional Memberships
- Member
